The US government will invest more than $ 3.2 billion in a new program whose goal is to obtain a medication against COVID-19 disease caused by a new type coronavirus. About this with reference to state bodies reported The New York Times.
“Let’s say, I wake up in the morning, I’m not good: I don’t feel tastes and smells, I’m in my throat. I call the doctor and say” I have COVID-19, write me a recipe “”, – outlined the future situation Infectionist of the country Dr. Anthony Faucci.
Investments will go to speed up the clinical tests of drugs, possibly suitable for this role. It is noted that in the optimistic scenario, the medicine will be confirmed by the end of this year. Approximately one third of the funds will go to research centers that develop quite new drugs – such that block the disease at an early stage or will help to cope with other infections that are potentially able to lead to a pandemic.
It is noted that last year the American authorities have allocated more than $ 18 billion to the development of the vaccine.
Coronavirus medicine is also developing in Russia: in April, the director of the Institute of Immunology of the FMBA of Russia, Musa Khaitov stated that the tests show the effectiveness of the drug “Mir-19”.